Spectral AI, Inc. 8-K

What Happened
Spectral AI, Inc. (MDAI) announced on March 18, 2026 that it was awarded $31.7 million from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to accelerate and support additional feature development for its DeepView® AI-driven burn wound system. The company furnished a press release about the award as Exhibit 99.1 to a Current Report on Form 8-K filed March 20, 2026 under Regulation FD.

Key Details

• BARDA award amount: $31.7 million.
• Purpose: to accelerate and support additional feature aspects of the DeepView® System (AI-driven burn wound technology).
• Announcement date: March 18, 2026; 8-K filed March 20, 2026.
• Press release included as Exhibit 99.1 to the 8-K.

Why It Matters
This award is a material government funding event for Spectral AI that directly targets development of its core DeepView product. For investors, the funding can accelerate product development and may influence the company’s R&D progress and timelines. Watch for future filings or company updates that disclose contract terms, milestones, how the funds will be recognized (e.g., grant vs. contract revenue), and any commercial or regulatory timelines tied to the award.